Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma: A Feasibility Phase II Randomized Clinical Trial ("URANUS")"

NCT02969083 is registered in ClinicalTrials.gov with The European Uro-Oncology Group as lead sponsor.

NCT NCT02969083
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02969083 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma: A Feasibility Phase II Randomized Clinical Trial ("URANUS")"
Lead sponsor
The European Uro-Oncology Group
Phase
Phase 2
Overall status
Unknown status
Start date
May 28, 2018
Completion date
December 31, 2025
Enrollment
200 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

upper tract urothelial carcinoma